This platform will play an important part of Boehringer Ingelheim’s broader strategy to capture translational disease insights from large external healthcare biobanks and ultimately to accelerate the development of innovative medicines.
What is your need?
Make your biomedical data easily accessible and securely usable in your environment. Accelerate breakthroughs and cure diseases.
Align your data landscape & research needs, shape your data acquisition strategy & realise the potential of your data.
Blueprinted, future-proofed infrastructure giving you the competitive advantage. Your federated architecture & cloud specialists.
From Nextflow to advanced federated AI – answer your research questions by building simple, yet powerful, workflows in the language of your choice.
Become part of the world’s largest federated network, gain competitive advantage & create commercially sustainable solutions.
How our platform has helped others
The advanced capabilities of Lifebit’s Trusted Research Environment, coupled with our focus to reimagine the infrastructure of cancer care, will enable us to unlock the potential of cancer data.
I am incredibly excited that Lifebit and AWS joined us to launch the next phase of our research capabilities.
Lifebit is excited to announce its sponsorship of Europe's largest congress on October 4th, 2023, where prominent leaders from the medicine and healthcare sectors will convene to discuss crucial topics related to digital transformation in pharmaceutical development and healthcare. We look forward to seeing you in october.